Optical tomographic monitoring of vascular responses to anti-angiogenic drugs in preclinical tumor models

Molly L. Flexman; Hyun K. Kim; Sonia L. Hernandez; Jianzhong Huang; Tessa J. Johung; Jonghwan Lee; Darrell J. Yamashiro; Jessica J. Kandel; Andreas H. Hielscher

doi:10.1117/12.875422

1 March 2011 Optical tomographic monitoring of vascular responses to anti-angiogenic drugs in preclinical tumor models

Molly L. Flexman, Hyun K. Kim, Sonia L. Hernandez, Jianzhong Huang, Tessa J. Johung, Jonghwan Lee, Darrell J. Yamashiro, Jessica J. Kandel, Andreas H. Hielscher

Author Affiliations +

Proceedings Volume 7896, Optical Tomography and Spectroscopy of Tissue IX; 789627 (2011) https://doi.org/10.1117/12.875422
Event: SPIE BiOS, 2011, San Francisco, California, United States

Abstract

It is well acknowledged that treatment efficacy could be increased and unnecessary toxicities reduced if a rapid assessment strategy were available to allow individual tailoring of cancer therapy. In this work we focus on using optical tomographic imaging to detect tumor response to anti-angiogenic treatment within the first 5 days of therapy. For this study we used two models with well-characterized and divergent responses to inhibition of vascular endothelial growth factor (VEGF). SK-NEP and NGP cells were implanted intrarenally into NCR nude mice and the resulting tumors were monitored until a threshold of 1-2 g was reached. Optical tomographic imaging with a dual-wavelength (λ = 765nm and 830nm) continuous wave system, was performed prior to the first treatment with the anti-VEGF bevacizumab (BV), as well as 1, 3, and 5 days later. We found that the SK-NEP tumor model, known to be responsive to BV treatment, shows a decrease in hemoglobin levels over the 5 days. Mice implanted with the NGP tumor model, known to be less responsive to treatment, do not show such decreases. These results were further validated with histopathological findings that showed a decrease in tumor vascularization in treated SK-NEP mice. These results suggest that optical tomography is a promising tool for monitoring early tumor response to drug therapy.

Citation Download Citation

Molly L. Flexman, Hyun K. Kim, Sonia L. Hernandez, Jianzhong Huang, Tessa J. Johung, Jonghwan Lee, Darrell J. Yamashiro, Jessica J. Kandel, and Andreas H. Hielscher "Optical tomographic monitoring of vascular responses to anti-angiogenic drugs in preclinical tumor models", Proc. SPIE 7896, Optical Tomography and Spectroscopy of Tissue IX, 789627 (1 March 2011); https://doi.org/10.1117/12.875422

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available